Comparison of the Effectiveness of EEG-Based Neurofeedback Therapy Versus Conventional Therapies (Medication and Mindfulness-Based Cognitive Behavioral Therapy) in Improving Symptoms of Obsessive-Compulsive Disorder Patients

Comparison of the Effectiveness of EEG-Based Neurofeedback Therapy Versus Conventional Therapies (Medication and Mindfulness-Based Cognitive Behavioral Therapy) in Improving Symptoms of Obsessive-Compulsive Disorder Patients: A Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250304064931N1

Enrollment

Registered

2025-05-29

Start date

2025-04-28

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder (OCD) is a chronic mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) that an individual feels compelled to perform. These symptoms can cause significant distress, interfere with daily functioning, and diminish quality of life. The study focused on understanding the clinical presentation, underlying mechanisms, and potential interventions for individuals affected by OCD. Emphasis

Interventions

Intervention 1: Control group: Group A (treatment as usual). Intervention 2: Intervention group: Group B (mindfulness based cognitive therapy with medication). Intervention 3: Intervention group: roup

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Diagnosed with Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria. Aged between 18 and 40 years. No neurological disorder (stroke, head injury, epilepsy, dementia). No severe medical conditions (e.g., hepatic failure, renal failure). No history of psycho-surgery or neurosurgical procedures.

Exclusion criteria

Exclusion criteria: Psychiatric comorbidity (schizophrenia, psychosis, delusional disorders). Substance abuse or drug dependence.

Design outcomes

Primary

Measure	Time frame
Obsessive compulsive disorder. Timepoint: Before intervention (baseline), and on every follow up (monthly in group A for 3 months which is treatment as usual group, and weekly in treatment group B, C and D for 12weeks. Method of measurement: Yale brown obsessive compulsive scale (YBOCS).	—

Countries

Pakistan

Contacts

Public ContactSumaira Mehreen

University of Peshawar

sumaira.mehreen@lrh.edu.pk+92 345 9093113

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026